SPY363.22+5.76 1.61%
DIA300.43+4.54 1.53%
IXIC12,036.79+156.15 1.31%

Navidea Biopharmaceutical Q3 EPS $(0.13) Misses $(0.09) Estimate, Sales $268.00K Beat $150.00K Estimate

Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 23.53 percent increase over losses of $(0.17) per

· 11/12/2020 16:03
Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 23.53 percent increase over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $268.00 thousand which beat the analyst consensus estimate of $150.00 thousand by 78.67 percent. This is a 13.17 percent increase over sales of $236.81 thousand the same period last year.